Craft

Berry Genomics

Stock Price

¥9.6

2024-10-29

Market Capitalization

¥3.3 B

2024-10-29

Revenue

¥1 B

FY, 2024

Berry Genomics Summary

Company Summary

Overview
Berry Genomics (贝瑞基因) is a biotechnology company that develops sequencing-based integrated solutions for life sciences and clinical applications. The company focuses on genetic testing and oncology testing.
Type
Public
Status
Active
Founded
2010
HQ
CN | view all locations
Website
https://www.berrygenomics.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

LocationsView all

1 location detected

  • Beijing Shi HQ

    China

Berry Genomics Financials

Summary Financials

Revenue (Q1, 2026)
¥209.7M
Gross profit (Q1, 2026)
¥107.7M
Net income (Q1, 2026)
(¥19.1M)
Cash (Q1, 2026)
¥301.6M
EBIT (Q1, 2026)
(¥15.9M)
Enterprise value
$3.3B

Footer menu